Posted innews Pediatrics Respiratory
Budesonide-Formoterol Reliever Therapy Demonstrates Superiority over Salbutamol in Children with Mild Asthma: Insights from the CARE Trial
The CARE trial shows that budesonide-formoterol reliever monotherapy significantly reduces asthma attack rates compared to salbutamol in children aged 5-15 years with mild asthma, with comparable safety over 52 weeks.